Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma-a single-center retrospective study.
Neurol Sci
; 45(6): 2931-2934, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38326666
Full text:
1
Database:
MEDLINE
Main subject:
Central Nervous System Neoplasms
/
Rituximab
/
Lenalidomide
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Neurol Sci
Journal subject:
NEUROLOGIA
Year:
2024
Type:
Article
Affiliation country:
China